Prepare an IND application with CMC readiness review, phase-appropriate controls, and senior FDA submission support. Request a scoping call.
Form 483 response support turns observations into CAPA with verifiable effectiveness and fast retrieval. Reduce follow-up risk and regain control. Ask for a quick estimate.
First FDA inspection readiness keeps evidence retrievable across SOPs, data, and vendors. Reduce surprises and move faster. Request a scoping call.
The journey from preclinical research to an Investigational New Drug (IND) filing marks a pivotal phase in drug development. For biotech startups and pharmaceutical innovators,